[1] Burkett WC, Soper JT. A review of current management of placental site trophoblastic tumor and epithelioid trophoblastic tumor. Obstet Gynecol Surv, 2022; 77, 101−10. doi:  10.1097/OGX.0000000000000978
[2] Liu W, Zhao W, Huang XF. Outcomes and prognostic factors of placental-site trophoblastic tumor: a retrospective study of 58 cases. Arch Gynecol Obstet, 2022; 306, 1633−41. doi:  10.1007/s00404-022-06502-7
[3] Kaur B. Pathology of gestational trophoblastic disease (GTD). Best Pract Res Clin Obstet Gynaecol, 2021; 74, 3−28. doi:  10.1016/j.bpobgyn.2021.02.005
[4] Froeling FEM, Ramaswami R, Papanastasopoulos P, et al. Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours. Br J Cancer, 2019; 120, 587−94. doi:  10.1038/s41416-019-0402-0
[5] Zhou Y, Lu H, Yu C, et al. Sonographic characteristics of placental site trophoblastic tumor. Ultrasound Obstet Gynecol, 2013; 41, 679−84. doi:  10.1002/uog.12269
[6] Nakata M, Honda H, Iwama A, et al. WNT5A plays a critical role in anal opening in mice at an early stage of embryonic development. Pediatr Surg Int, 2022; 38, 743−7. doi:  10.1007/s00383-022-05103-4
[7] Bueno MLP, Saad STO, Roversi FM. WNT5A in tumor development and progression: a comprehensive review. Biomed Pharmacother, 2022; 155, 113599. doi:  10.1016/j.biopha.2022.113599
[8] Cao J, Xiao CC, Fong CJTH, et al. Expression and regulatory network analysis of function of small nucleolar RNA host gene 4 in hepatocellular carcinoma. J Clin Transl Hepatol, 2022; 10, 297−307. doi:  10.14218/JCTH.2020.00175
[9] Tian Q, Gu YF, Wang FF, et al. Upregulation of miRNA-154-5p prevents the tumorigenesis of osteosarcoma. Biomed Pharmacother, 2020; 124, 109884. doi:  10.1016/j.biopha.2020.109884
[10] Wang KS, Ma F, Arai S, et al. WNT5A signaling through ROR2 activates the hippo pathway to suppress YAP1 activity and tumor growth. Cancer Res, 2023; 83, 1016−30.